ACE2 is considered as a potential therapeutic target of the RAS for the treatment of hypertension and heart failure and converts Ang II into Ang-(1–7), which, by virtue of its actions on the Mas receptor, opposes the molecular and cellular effects of Ang II [12–14]. Here, AGT is linked to hypertensive disorder.